Astrana Health, Inc. (ASTH) - Form 8-K Summary
Business Context and Reporting Period
Astrana Health, Inc., a Delaware corporation, filed this Current Report on Form 8-K on February 27, 2025. The filing announces the Company's financial results for the three and twelve months ended December 31, 2024. The Company's principal executive offices are located in Alhambra, California, and its common stock trades on The Nasdaq Stock Market LLC under the symbol "ASTH."
Key Financial Metrics
The provided filing text serves as a cover document referencing the financial results but does not contain specific numerical data. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. These figures are contained within the referenced press release (Exhibit 99.1) and supplemental data (Exhibit 99.2), which are incorporated by reference but not included in the source text provided.
Material Changes
No material changes versus the prior comparable period are detailed in the text of this Form 8-K. The document solely indicates that results for the periods ended December 31, 2024, have been issued.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The report notes that the information furnished pursuant to Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act nor incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash position figures for Q4 and FY 2024.
- Examine Exhibit 99.2 (Supplemental Data) for detailed operational metrics and segment performance.
- Verify the Company's liquidity position and runway based on the cash flow statement in the referenced exhibits.
- Check for any updated guidance or strategic shifts mentioned in the full press release text.